Tumor-propagating cells (TPCs) share self-renewal properties with normal stem cells and
drive continued tumor growth. However, mechanisms regulating TPC self-renewal are …

Rhabdomyosarcoma (RMS) is a pediatric myogenic-derived soft tissue sarcoma that
includes two major histopathological subtypes: embryonal and alveolar. The majority of …

Rhabdomyosarcoma (RMS) is a pediatric myogenic soft tissue sarcoma. The Fusion-
Positive (FP) subtype expresses the chimeric protein PAX3-FOXO1 (P3F) while the Fusion …

Rhabdomyosarcoma (RMS) is a paediatric soft-tissue sarcoma arising from skeletal muscle
precursors coexpressing markers of proliferation and differentiation. Inducers of myogenic …

Rhabdomyosarcoma (RMS), a cancer characterized by skeletal muscle features, is the most
common soft-tissue sarcoma of childhood. While low-and intermediate-risk groups have …

Purpose: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood
and remains refractory to combined-modality therapy in patients with high risk disease. In …

Rhabdomyosarcoma (RMS) is a pediatric malignacy of muscle with myogenic regulatory
transcription factors MYOD and MYF5 being expressed in this disease. Consensus in the …

Rhabdomyosarcoma is the most common pediatric soft tissue tumor, comprising two major
subtypes: the PAX3/7-FOXO1 fusion-negative embryonal and the PAX3/7-FOXO1 fusion …

Rhabdomyosarcoma (RMS) is an aggressive pediatric malignancy of the muscle, that
includes Fusion Positive (FP)-RMS harboring PAX3/7-FOXO1 and Fusion Negative (FN) …

Embryonal rhabdomyosarcoma (ERMS) is an aggressive pediatric sarcoma of muscle. Here,
we show that ERMS-propagating potential is confined to myf5+ cells and can be visualized …